Muriel Le Romancer Selected Research

Muriel Le Romancer Research Topics

Disease

30	Breast Neoplasms (Breast Cancer) 03/2024 - 03/2010
21	Neoplasms (Cancer) 10/2023 - 07/2008
4	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2021
4	Carcinogenesis 11/2020 - 10/2011
2	Triple Negative Breast Neoplasms 10/2023 - 01/2022
1	Residual Neoplasm 10/2023
1	Androgen-Insensitivity Syndrome (Testicular Feminization) 01/2023
1	Inflammation (Inflammations) 01/2021
1	Prostatic Intraepithelial Neoplasia 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020
1	Melanoma (Melanoma, Malignant) 11/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 01/2021 - 06/2010
9	Estrogens (Estrogen)FDA Link 01/2023 - 03/2010
6	Estrogen Receptor alphaIBA 01/2023 - 07/2008
5	Tamoxifen FDA LinkGeneric 01/2023 - 12/2014
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 03/2010
4	Hormones (Hormone)IBA 08/2022 - 01/2019
4	Progesterone Receptors (Progesterone Receptor)IBA 08/2022 - 01/2020
4	Arginine (L-Arginine)FDA Link 06/2020 - 03/2010
3	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2014
3	Progesterone FDA LinkGeneric 08/2022 - 01/2020
3	Phenobarbital (Luminal)FDA Link 12/2021 - 12/2014
3	EnzymesIBA 10/2016 - 03/2010
2	MethyltransferasesIBA 03/2024 - 01/2024
2	ChromatinIBA 01/2023 - 01/2019
2	Steroid Receptors (Steroid Receptor)IBA 08/2022 - 12/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2014
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 04/2021 - 09/2014
2	Transcription Factors (Transcription Factor)IBA 06/2020 - 01/2020
2	FurinIBA 01/2020 - 01/2020
2	Thioctic Acid (Lipoic Acid)IBA 01/2020 - 01/2020
1	Lysine (L-Lysine)FDA Link 01/2024
1	GlucocorticoidsIBA 10/2023
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2022
1	Everolimus FDA Link 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	MTOR InhibitorsIBA 12/2021
1	CateninsIBA 08/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2021
1	AlpelisibIBA 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Endocrine DisruptorsIBA 11/2020
1	ras ProteinsIBA 11/2020
1	palbociclibIBA 01/2020
1	CadmiumIBA 01/2020
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2020
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2020
1	human PRMT2 proteinIBA 01/2019
1	CarcinogensIBA 01/2019
1	DioxinsIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Bone Morphogenetic Protein 2IBA 01/2017
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2017
1	Formaldehyde (Formol)FDA Link 11/2012
1	ParaffinIBA 11/2012

Therapy/Procedure

10	Therapeutics 01/2024 - 10/2011
3	Drug Therapy (Chemotherapy) 10/2023 - 04/2021
3	Ligation 06/2019 - 11/2012
1	Immunotherapy 10/2023
1	Castration 08/2021